Pfizer’s oral pill, which is currently under testing, would prevent the virus from replicating in the nose, throat, and lungs. It is intended to cure the body upon first signs of infection; thus, if it came to market, it would make the company a fortune because it would be sold to both the vaccinated and unvaccinated. Both populations are still being infected with COVID, illustrating the limited effectiveness of the vaccines. Continue reading
Pfizer’s COVID-19 Pill Under Development Already Exists in Several Other Forms
Reply